APA (7th ed.) Citation

R, B., L, H., K, H., M, A., K, Z., R, R., . . . J, G. (2018). Allogeneic transplantation of programmable cells of monocytic origin (PCMO) improves angiogenesis and tissue recovery in critical limb ischemia (CLI): A translational approach. Stem cell research & therapy, 9(1), 117. https://doi.org/10.1186/s13287-018-0871-8

Chicago Style (17th ed.) Citation

R, Berndt, et al. "Allogeneic Transplantation of Programmable Cells of Monocytic Origin (PCMO) Improves Angiogenesis and Tissue Recovery in Critical Limb Ischemia (CLI): A Translational Approach." Stem Cell Research & Therapy 9, no. 1 (2018): 117. https://doi.org/10.1186/s13287-018-0871-8.

MLA (9th ed.) Citation

R, Berndt, et al. "Allogeneic Transplantation of Programmable Cells of Monocytic Origin (PCMO) Improves Angiogenesis and Tissue Recovery in Critical Limb Ischemia (CLI): A Translational Approach." Stem Cell Research & Therapy, vol. 9, no. 1, 2018, p. 117, https://doi.org/10.1186/s13287-018-0871-8.